Sort
30,917 grants matching “tumor microenvironment”
Next-Gen Oncopathology Program
$361,841Ethel Cesarman · Weill Medical Coll Of Cornell Univ · T32 · FY2023 · CA
Stimulating Lymphocyte Activation Combined with Inhibition of Immunosuppressive Signals in Colon Cancer Metastases
$361,836Ajay V. Maker · University Of California, San Francisco · R37 · FY2025 · CA
Role of the microenvironment in ovarian cancer metastasis
$361,740Katherine Cynthia Fuh · University Of California, San Francisco · R01 · FY2023 · CA
Project 3: Sex-specific differences in the tumor microenvironment alter glioblastoma growth
$361,725Justin D. Lathia · Cleveland Clinic Lerner Com-Cwru · P01 · FY2023 · CA
Skin Stem Cells: Purification and Characterization
$361,712Elaine Fuchs · Rockefeller University · R01 · FY2021 · AR
Mechanisms of selective therapeutic synergy of PARP-inhibition and CTLA4 blockade engaged by interferon-gamma in the ovarian tumor microenvironment
$361,703Sarah Foster Adams · University Of New Mexico Health Scis Ctr · R37 · FY2019 · CA
Improved therapy for p53wt melanoma by functionally restoring the CDKN2A pathway
$361,688Ann Richmond · Vanderbilt University · R01 · FY2019 · CA
Multi-Scale Engineering of Heterogeneity in the Host-Aware Synthetic Gene Circuits
$361,686Xiaojun Tian · Arizona State University-Tempe Campus · R35 · FY2025 · GM
Role of the complement C3a receptor on immune and non immune intestinal barrier functions and microbiota in colorectal cancer development
$361,672Silvia Guglietta · Medical University Of South Carolina · R01 · FY2022 · CA
The role of HIF2alpha in colon carcinogenesis
$361,550Yatrik M Shah · University Of Michigan At Ann Arbor · R01 · FY2021 · CA
The role of HIF2alpha in colon carcinogenesis
$361,550Yatrik M Shah · University Of Michigan At Ann Arbor · R01 · FY2025 · CA
The role of HIF2alpha in colon carcinogenesis
$361,550Yatrik M Shah · University Of Michigan At Ann Arbor · R01 · FY2023 · CA
Biomimetic hydrogel niches to study the malignant phenotype of glioblastoma multiforme
$361,534Brendan A. Harley · University Of Illinois At Urbana-Champaign · R01 · FY2018 · CA
Mechanism of LSD1 in breast cancer metastasis suppression
$361,522Zhe Li · Brigham And Women'S Hospital · R01 · FY2024 · CA
The retinal microenvironment in diabetic retinopathy
$361,488Robert A Linsenmeier · Northwestern University · R01 · FY2014 · EY
Protocol Review and Monitoring System
$361,474Kyle C. Cuneo · University Of Michigan At Ann Arbor · P30 · FY2023 · CA
Molecular Targeted Radionuclide Therapy to Enhance Tumor Cell Susceptibility and Response to Immune Checkpoint Inhibition
$361,468Zachary Scott Morris · University Of Wisconsin-Madison · P01 · FY2024 · CA
Project 2: Cytoplasmic chromatin fragments (CCF) as a driver of liver cancer and target for intervention during aging
$361,442Peter D. Adams · Sanford Burnham Prebys Medical Discovery Institute · P01 · FY2025 · AG
Project 4: Interrogating and harnessing age-related IFN signaling and innate immunity in HCC prevention and therapy
$361,440Gen-Sheng Feng · Sanford Burnham Prebys Medical Discovery Institute · P01 · FY2025 · AG
Angiogenesis-targeting therapy for glioblastoma
$361,430Tracy T Batchelor · Massachusetts General Hospital · R01 · FY2014 · CA
The role of GPSM3 in tumor-promoting emergency myelopoiesis
$361,425Bin Zhang · Northwestern University At Chicago · R01 · FY2018 · CA
Role of Adenosine in TGF-beta Effects in Cancers
$361,425Sergey V. Novitskiy · Vanderbilt University Medical Center · R01 · FY2020 · CA
Elucidation and therapeutic exploitation of PAK mediated radioresistance
$361,425Sunil J Advani · University Of California, San Diego · R37 · FY2022 · CA
Role of Adenosine in TGF-beta Effects in Cancers
$361,425Sergey V. Novitskiy · Vanderbilt University Medical Center · R01 · FY2017 · CA
Role of Adenosine in TGF-beta Effects in Cancers
$361,425Sergey V. Novitskiy · Vanderbilt University Medical Center · R01 · FY2016 · CA